Valeria Bertagnolo

7PUBLICATIONS
9CO-AUTHORS
Regenerative medicine (incl. stem cells)Molecular targetsSolid tumoursPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 11, 2025
Vav1 Sustains the Expression of Insulin, PDX1 and miR-375 During Differentiation of hiPSCs to β Cells: A Potential Target to Improve the In Vitro Generation of Insulin-Producing Cells.

Marina Pierantoni, Valentina Zamarian, Federica Brugnoli

|Nov 03, 2025
Inhibition of cancerous properties of triple-negative MDA-MB-436 cells by targeting the K+ voltage-dependent Kv2.1 channel.

Rita Canella, Anna Terrazzan, Francesca P Carbone

|Nov 09, 2020
Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA).

Federica Brugnoli, Silvia Grassilli, Vincenzo Cardinale

|Oct 23, 2019
CD133 in Breast Cancer Cells: More than a Stem Cell Marker.

Federica Brugnoli, Silvia Grassilli, Yasamin Al-Qassab

|Dec 25, 2018
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.

Valeria Bertagnolo, Silvia Grassilli, Stefano Volinia

|Dec 01, 2018
Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells.

Yasamin Al-Qassab, Silvia Grassilli, Federica Brugnoli

Pageof 2

Frequent Collaborators

1 joint publications

Rita Canella

1 joint publications

Anna Terrazzan

1 joint publications

Francesca P Carbone

1 joint publications

Silvia Grassilli